News

DOC Fellowship: Investigating the genetic alterations behind profound immunodeficiencies.

Kaan Boztug Lab Members, News /

DOC Fellowship: Investigating the genetic alterations behind profound immunodeficiencies. Rare genetic alterations can derail immune development, causing immunodeficiencies and increasing the risk of childhood cancer. Hena Hadzimujagic, a PhD student in Kaan Boztug’s lab, has been awarded a prestigious DOC Fellowship by the Austrian Academy of Sciences to investigate the molecular mechanisms behind one of […]

DOC Fellowship: Investigating the genetic alterations behind profound immunodeficiencies. Read More »

When gene regulation goes wrong: uncovering the origins of leukemia

Davide Seruggia Team, News /

When gene regulation goes wrong: uncovering the origins of leukemia B cell development is a carefully controlled process. Genes must be switched on and off at the right time and in the right amount for healthy immune cells to form. When this precise sequence of events is altered, leukemia can develop instead. In a new

When gene regulation goes wrong: uncovering the origins of leukemia Read More »

Three research grants to strengthen precision medicine for pediatric cancer patients

Davide Seruggia Team, Florian Halbritter Team, George Cresswell Team, News, Sabine Taschner-Mandl Team, Uncategorized /

Three research grants to strengthen precision medicine for pediatric cancer patients The Vienna Science and Technology Fund (WWTF) has funded three research projects on pediatric cancer in the same funding round—all of them including researchers at St. Anna CCRI. The projects, designed in collaboration with scientists at other Viennese and German institutions, aim to improve

Three research grants to strengthen precision medicine for pediatric cancer patients Read More »

Florian Halbritter awarded Johann Wilhelm Ritter von Mannagetta Prize for Medicine

Florian Halbritter Team, News, Uncategorized /

Florian Halbritter awarded Johann Wilhelm Ritter von Mannagetta Prize for Medicine A computational scientist turned cancer researcher, Florian Halbritter is uncovering how developmental errors drive childhood cancer—work that has now earned him the Johann Wilhelm Ritter von Mannagetta Prize for Medicine from the Austrian Academy of Sciences (ÖAW). The award recognizes scientists under 45 working

Florian Halbritter awarded Johann Wilhelm Ritter von Mannagetta Prize for Medicine Read More »

A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart

Davide Seruggia Team, News, Uncategorized /

A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart (Vienna, 20.04.2026) – Researchers in the Seruggia group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and the CeMM Research Center for Molecular Medicine have uncovered a new way to tackle acute myeloid leukemia (AML) cells in children: Instead of directly targeting

A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart Read More »

Emerging Field Grant supports childhood cancer research

Davide Seruggia Team, Eleni Tomazou Team, News, Uncategorized /

Emerging Field Grant supports childhood cancer research As part of the excellent=austria initiative, the Austrian Science Fund (FWF) is promoting innovative research collaborations in Austria through its Emerging Fields programme. Over the next five years, selected consortia will work to develop new, highly innovative research fields. Following a competitive international review process focusing on scientific

Emerging Field Grant supports childhood cancer research Read More »

Researchers decode cancer’s genetic control panel one DNA letter at a time

Davide Seruggia Team, News, Uncategorized /

Researchers decode cancer’s genetic control panel one DNA letter at a time Scientists in Davide Seruggia’s group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI), together with collaborators at the Broad Institute of MIT and Harvard, have developed CRISPR-Millipede, a new CRISPR-based method that allows researchers to study regulatory DNA sequences at single-nucleotide

Researchers decode cancer’s genetic control panel one DNA letter at a time Read More »

Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development

Davide Seruggia Team, Florian Halbritter Team, News, Uncategorized /

Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development To study the molecular causes of pediatric cancer, scientists need to recreate complex developmental processes in the lab – an effort that often requires a great deal of trial and error. Scientists in the labs of Florian Halbritter and Davide Seruggia

Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development Read More »

Women in Science Day 2026

News /

Women in Science Day 2026: Then. Now. Tomorrow.  Every researcher’s journey begins with curiosity. A question asked as a child. A fascination with how the world works. Today, these childhood dreams live on in our labs. Our researchers are exploring, questioning, and pushing boundaries. Driven by the same curiosity, now paired with expertise, responsibility and purpose.

Women in Science Day 2026 Read More »

St. Anna CCRI Workshop Brings Together International Neuroblastoma Scientists 

News /

St. Anna CCRI Workshop Brings Together International Neuroblastoma Scientists  Hosted by St. Anna Children’s Cancer Research Institute Researchers Florian Halbritter, Polina Kameneva and Sabine Taschner-Mandl, the 2nd International Workshop on Innovative Models for Neuroblastoma Research brought together more than 70 scientists from 28 laboratories across 8 countries. Over two days, the program featured multiple scientific

St. Anna CCRI Workshop Brings Together International Neuroblastoma Scientists  Read More »

Chatting with Your Cells: Natural-Language AI for Single-Cell Data Analysis

News /

Chatting with Your Cells: Natural-Language AI for Single-Cell Data Analysis Single-cell sequencing provides great insights into the inner workings of cells – but making sense of the data requires advanced bioinformatics skills. Researchers at CeMM, Medical University of Vienna, and St. Anna Children’s Cancer Research Institute have now developed an artificial intelligence (AI) method and

Chatting with Your Cells: Natural-Language AI for Single-Cell Data Analysis Read More »

St. Anna CCRI Appoints New Scientific Directors: Eleni Tomazou and Sabine Taschner-Mandl

News /

St. Anna CCRI Appoints New Scientific Directors: Eleni Tomazou and Sabine Taschner-Mandl (Vienna, October 2025) The St. Anna Children’s Cancer Research Institute (St. Anna CCRI) is pleased to announce the appointment of Dr. Eleni Tomazou and Dr. Sabine Taschner-Mandl, two internationally recognized experts, as new Scientific Directors. With their complementary expertise and shared dedication to

St. Anna CCRI Appoints New Scientific Directors: Eleni Tomazou and Sabine Taschner-Mandl Read More »

Career Paths in Biomedical Science

News /

Career Paths in Biomedical Science Insights from St. Anna CCRI’s First Open House Event St. Anna Children’s Cancer Research Institute (St. Anna CCRI) recently opened its doors for a career-focused evening designed to give young people insight into the diverse professional opportunities in biomedical science. The event attracted participants at various career stages for an

Career Paths in Biomedical Science Read More »

Better Therapy Selection for Childhood Leukemia

News /

Better Therapy Selection for Childhood Leukemia Despite decades of optimization of treatment protocols, the prognosis for acute myeloid leukemia in children (pediatric AML, pedAML) remains poor for many patients. A research team from St. Anna Children’s Cancer Research Institute (St. Anna CCRI), the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences,

Better Therapy Selection for Childhood Leukemia Read More »